APAR has demonstrated the potential efficacy of its home beauty device technology for treating hair loss.
On September 13, APAR announced that the results of a study on scalp health improvement and androgenetic alopecia treatment, conducted in collaboration with academia, were published in the international journal Pharmaceutics on August 28. This journal ranks in the top 10% of pharmacology in the Journal Citation Reports (JCR).
The study utilized the RF microporation technology applied in the airshot mode of the home beauty device 'MedCube Ageal Booster Pro X2.' Researchers evaluated how this technology, combined with the topical treatment minoxidil, affected skin delivery and hair regeneration in animal models.
RF microporation is a technique that temporarily creates micro-delivery pathways in the skin's stratum corneum using radiofrequency energy, facilitating the internal delivery of active ingredients applied to the skin.
Preclinical results showed that when RF microporation was used alongside minoxidil, the amount of minoxidil deposited in the epidermis and dermis increased by up to 2.4 times compared to using minoxidil alone. In animal models of androgenetic alopecia, significant improvements were observed in hair coverage, length, and thickness.
APAR emphasizes the significance of this study in confirming the potential to enhance the skin delivery efficiency of topical hair loss treatments. Since topical agents like minoxidil must penetrate the skin's stratum corneum to deliver active ingredients to the skin and hair follicles, delivery efficiency is a crucial factor in the treatment process.
APAR plans to conduct further clinical studies to validate the applicability, efficacy, and safety of this technology in the field of hair loss treatment. They are also pursuing the development of a platform technology to assist in the delivery of various active ingredients for scalp and hair.
An APAR representative stated, "The publication of this paper in an international journal demonstrates the scientific validation of our device technology's operating principles and efficacy. We will continue to strive to develop new technologies and products based on our research and development competitiveness."
Meanwhile, the 'Booster Pro X2' is the next-generation model released approximately two and a half years after the flagship product 'Booster Pro.' It employs a dual care method to enhance energy delivery and cosmetic absorption efficiency compared to previous models. The device is designed with four electrodes on its surface to simultaneously deliver energy to both the skin's surface and deeper layers.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.